Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Hans-Peter Hartung

1-50 of 497 results

View this query on the Wikidata Query Service
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

scientific article
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

scientific article
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

scientific article
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

scientific article
Guillain–Barré Syndrome

scientific article
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

scientific article
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

scientific article (publication date: November 2012)
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

scientific article
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

scientific article published on 21 December 2017
Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

scientific article
Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

scientific article published in December 1996
Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis

scientific article
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

scientific article published on 21 December 2016
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

scientific article published on 21 December 2016
Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds

scientific article published in April 1999
New concepts in the immunopathogenesis of multiple sclerosis

scientific article
Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy

scientific article
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci

scientific article
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

scientific article published on 2 September 2009
Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

scientific article
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

scientific article
Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis

scientific article published on 30 March 2005
Chronic inflammatory demyelinating polyneuropathy.

scientific article
Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale

scientific article
Vitamin D as an early predictor of multiple sclerosis activity and progression

scientific article published on March 2014
MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study

scientific article published on July 1999
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

scientific article
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

scientific article (publication date: August 2011)
Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica

scientific article published on February 1, 2012
The role of macrophages in immune-mediated damage to the peripheral nervous system

scientific article
Acute disseminated encephalomyelitis: an update

scientific article
MRI evidence of past cerebral microbleeds in a healthy elderly population

scientific article published in March 1999
Immunopathogenesis and immunotherapy of multiple sclerosis

scientific article published on April 2006
Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part I.

scientific article published on February 1995
Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial

scientific article published on March 6, 2014
Guillain-Barré syndrome after exposure to influenza virus

scientific article published on September 1, 2010
Animal models for autoimmune demyelinating disorders of the nervous system

scientific article
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study

scientific article published on May 13, 2011
The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans

scientific article
Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis

scholarly article
Macrophages prevent hemorrhagic infarct transformation in murine stroke models

scientific article published on June 2012
Statins as immunomodulators: comparison with interferon-beta 1b in MS.

scientific article published in October 2002
Enhancing remyelination in disease--can we wrap it up?

scientific article published on April 19, 2011
Lack of association between antimyelin antibodies and progression to multiple sclerosis

scientific article
Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

scientific article
Inflammatory mediators in demyelinating disorders of the CNS and PNS

scientific article published on October 1, 1992
Molecular mechanisms of microglial activation

scientific article published on January 1996
Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring

scientific article
MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study

scientific article
Animal models of multiple sclerosis--potentials and limitations

scientific article published on 15 June 2010

Paulina is supported by:

About Paulina

Help